Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jun Shirakawa

Showing results (1-10 of 106) with videos related to

Pageof 11
Sort By:
Journal of Diabetes Investigation|March 5, 2023
Signaling pathways that regulate adaptive β-cell proliferation for the treatment of diabetesJun Shirakawa
Diabetology International|September 27, 2021
Translational research on human pancreatic β-cell mass expansion for the treatment of diabetesJun Shirakawa
Journal of Diabetes Investigation|November 26, 2025
Gαs defines the fundamental coupling mechanism of insulin secretionJun Shirakawa
Journal of Diabetes Investigation|September 16, 2021
Pancreatic β-cell fate in subjects with COVID-19Jun Shirakawa
Journal of Biochemistry|November 12, 2025
The insulin/IGF receptor puzzle in pancreatic β-cell recovery: A missing link for diabetes therapy?Jun Shirakawa
Journal of Diabetes Investigation|August 2, 2016
Glucose- or insulin resistance-mediated β-cell replication: PKCζ integrates the proliferative signalingJun Shirakawa, Yasuo Terauchi
Annals of Translational Medicine|June 30, 2018
SUSTAINable management of type 2 diabetes: feasibility of use and safety of semaglutideJun Shirakawa, Yasuo Terauchi
Journal of Diabetes Investigation|November 21, 2014
Selective and sequential loss of transcriptional factors: A hallmark of β-cell failure in type 2 diabetes?Jun Shirakawa, Yasuo Terauchi
Endocrine Journal|November 8, 2019
Newer perspective on the coupling between glucose-mediated signaling and β-cell functionalityJun Shirakawa, Yasuo Terauchi
Journal of Diabetes Investigation|November 28, 2019
Potential linkage between dipeptidyl peptidase-4 inhibitor use and the risk of pancreatitis/pancreatic cancerJun Shirakawa, Yasuo Terauchi
Pageof 11

Showing results (1-10 of 106) with videos related to

Sort By:
Pageof 11
Journal of Diabetes Investigation|March 5, 2023
Signaling pathways that regulate adaptive β-cell proliferation for the treatment of diabetesJun Shirakawa
Diabetology International|September 27, 2021
Translational research on human pancreatic β-cell mass expansion for the treatment of diabetesJun Shirakawa
Journal of Diabetes Investigation|November 26, 2025
Gαs defines the fundamental coupling mechanism of insulin secretionJun Shirakawa
Journal of Diabetes Investigation|September 16, 2021
Pancreatic β-cell fate in subjects with COVID-19Jun Shirakawa
Journal of Biochemistry|November 12, 2025
The insulin/IGF receptor puzzle in pancreatic β-cell recovery: A missing link for diabetes therapy?Jun Shirakawa
Journal of Diabetes Investigation|August 2, 2016
Glucose- or insulin resistance-mediated β-cell replication: PKCζ integrates the proliferative signalingJun Shirakawa, Yasuo Terauchi
Annals of Translational Medicine|June 30, 2018
SUSTAINable management of type 2 diabetes: feasibility of use and safety of semaglutideJun Shirakawa, Yasuo Terauchi
Journal of Diabetes Investigation|November 21, 2014
Selective and sequential loss of transcriptional factors: A hallmark of β-cell failure in type 2 diabetes?Jun Shirakawa, Yasuo Terauchi
Endocrine Journal|November 8, 2019
Newer perspective on the coupling between glucose-mediated signaling and β-cell functionalityJun Shirakawa, Yasuo Terauchi
Journal of Diabetes Investigation|November 28, 2019
Potential linkage between dipeptidyl peptidase-4 inhibitor use and the risk of pancreatitis/pancreatic cancerJun Shirakawa, Yasuo Terauchi
Pageof 11